Oncostellae: Funding, Investors & Team (Sep 2026)
In 2013, Oncostellae was established by a group of researchers specializing in chemistry, biochemistry, and pharmacology. Their goal is to develop small molecule drugs for cancer treatment by creating research programs focused on new modulators of known cancer targets such as nuclear receptors and kinases. The company's approach involves minimal staffing and prioritizing project management, medicinal chemistry, and in vitro pharmacology. Other aspects of the research and development process, such as in vivo pharmacology and clinical trials, are outsourced to qualified partners. Ultimately, Oncostellae aims to license a clinical drug candidate, along with associated intellectual property and data, to a larger pharmaceutical or biotech company.
Oncostellae has raised $3.4M across 2 funding rounds on record, the most recent an undisclosed round announced in Mar 2024.
Oncostellae Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Oncostellae Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Oncostellae raised $3.4M in an undisclosed round announced in Nov 2022.
1.3 years later, an undisclosed round was announced in Mar 2024 with no disclosed amount.
Oncostellae Founders and Leadership Team
No contact details are on record for this team yet.
Oncostellae Funding Compared to Other Health Care Startups
Funded Startups Like Oncostellae in Health Care and Orense
Companies Similar to Oncostellae
Valentia Foundation supports individuals with intellectual disabilities and Autism Spectrum Disorder (ASD),…
BASE4 Biosciences is a precision health firm developing a new layer of preventive medicine.
Opportunity Health is an innovative Navarrese company
Qida is a company that provides high-quality and compassionate home care for elderly or dependent…
2Eyes Vision, a company based in Madrid and established in 2015 as a spin off from CSIC, is focused on…
Healthy Minds offers business-to-business mental health solutions for companies that are powered by…
Gestcompost is dedicated to managing organic and biodegradable waste.
Ysium Medical provides cutting-edge technological solutions for the future of healthcare.
Geniova, a Spanish start-up, focuses on invisible orthodontics by combining a patented method using a lingual…
CORIFY Care is a start-up funded by main world-wide experts on cardiac arrhythmias which is going to…
Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength…
NeuronUP is a platform that allows professionals to access exercise routines for their patients at any time…
Oncostellae Funding FAQs
What does Oncostellae do?
In 2013, Oncostellae was established by a group of researchers specializing in chemistry, biochemistry, and pharmacology. Their goal is to develop small molecule drugs for cancer treatment by creating research programs focused on new modulators of known cancer targets such as nuclear receptors and kinases. The company's approach involves minimal staffing and prioritizing project management, medicinal chemistry, and in vitro pharmacology. Other aspects of the research and development process, such as in vivo pharmacology and clinical trials, are outsourced to qualified partners. Ultimately, Oncostellae aims to license a clinical drug candidate, along with associated intellectual property and data, to a larger pharmaceutical or biotech company.
How much funding has Oncostellae raised?
Oncostellae has raised $3.4M across 2 rounds on record.
When did Oncostellae last raise funding?
Oncostellae's most recent funding round on record was announced in Mar 2024. The amount was not disclosed.
Who founded Oncostellae?
FundedIQ lists Julio Castro Palomino (Founder) at Oncostellae.
Where is Oncostellae headquartered?
Oncostellae is based in Orense, Galicia, Spain.
How many employees does Oncostellae have?
Oncostellae is in the 11-50 employee band.
About FundedIQ's Oncostellae Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oncostellae is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.